These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Detection and evaluation of chronic kidney disease. Snyder S; Pendergraph B Am Fam Physician; 2005 Nov; 72(9):1723-32. PubMed ID: 16300034 [TBL] [Abstract][Full Text] [Related]
28. Screening for chronic kidney disease: which strategy? Hallan SI; Stevens P J Nephrol; 2010; 23(2):147-55. PubMed ID: 20155721 [TBL] [Abstract][Full Text] [Related]
29. Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent? Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP Curr Vasc Pharmacol; 2012 May; 10(3):374-7. PubMed ID: 22272896 [TBL] [Abstract][Full Text] [Related]
30. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Hoerger TJ; Wittenborn JS; Segel JE; Burrows NR; Imai K; Eggers P; Pavkov ME; Jordan R; Hailpern SM; Schoolwerth AC; Williams DE; Am J Kidney Dis; 2010 Mar; 55(3):452-62. PubMed ID: 20116911 [TBL] [Abstract][Full Text] [Related]
31. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541 [TBL] [Abstract][Full Text] [Related]
32. A predictive model for progression of chronic kidney disease to kidney failure. Tangri N; Stevens LA; Griffith J; Tighiouart H; Djurdjev O; Naimark D; Levin A; Levey AS JAMA; 2011 Apr; 305(15):1553-9. PubMed ID: 21482743 [TBL] [Abstract][Full Text] [Related]
33. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Eriksen BO; Ingebretsen OC Kidney Int; 2007 Nov; 72(10):1242-8. PubMed ID: 17687256 [TBL] [Abstract][Full Text] [Related]
34. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD. Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166 [TBL] [Abstract][Full Text] [Related]
35. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction. Chang A; Kramer H Nephron Clin Pract; 2011; 119(2):c171-7; discussion c177-8. PubMed ID: 21811078 [TBL] [Abstract][Full Text] [Related]
36. Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician. Vassalotti JA; Centor R; Turner BJ; Greer RC; Choi M; Sequist TD; Am J Med; 2016 Feb; 129(2):153-162.e7. PubMed ID: 26391748 [TBL] [Abstract][Full Text] [Related]
37. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
38. The primary care physician: nephrology interface for the identification and treatment of chronic kidney disease. Stevens PE; Farmer CK; Hallan SI J Nephrol; 2010; 23(1):23-32. PubMed ID: 20091483 [TBL] [Abstract][Full Text] [Related]
39. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden. Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591 [TBL] [Abstract][Full Text] [Related]
40. [Chronic kidney disease: novelties and scope of follow-up by the primary care physician]. Sánchez Hernández R Nefrologia; 2008; 28 Suppl 5():113-7. PubMed ID: 18847430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]